Wurmlingen, Germany

Claudia Haertel

This inventor holds 1 USPTO granted patent. Top assignee: Aesculap Ag. Active years: 2012.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Haertel: Innovator in Surgical Adhesives

Introduction

Claudia Haertel is a notable inventor based in Wurmlingen, Germany. She has made significant contributions to the field of surgical therapy through her innovative adhesive compositions. Her work is particularly relevant in enhancing surgical procedures and patient outcomes.

Latest Patents

Claudia Haertel holds a patent for "Adhesive compositions for use in surgical therapy." This patent describes an adhesive composition that includes a liquid mixture of cyanoacrylate monomers and at least one plasticizer, with the proportion of the plasticizer exceeding 10% by weight. Additionally, the composition incorporates an aqueous liquid containing compounds such as borate salt, basic amino acid, gelatin, and gelatin derivatives. This innovative approach aims to improve the effectiveness and safety of surgical adhesives.

Career Highlights

Claudia is currently employed at Aesculap AG, a company renowned for its medical technology and surgical instruments. Her role at Aesculap AG allows her to apply her expertise in developing advanced adhesive solutions for surgical applications.

Collaborations

Throughout her career, Claudia has collaborated with talented professionals, including Anja Baiker and Erich Odermatt. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Claudia Haertel's innovative work in surgical adhesives exemplifies her commitment to improving medical practices. Her patent and contributions to Aesculap AG highlight her role as a leading inventor in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…